Is 0.01% Atropine Sulfate Eye Drops (EIKANCE) a prescription drug?
0.01% Atropine Sulfate Eye Drops (EIKANCE) is mainly used to control myopia in children and adolescents and belongs to the category of prescription ophthalmic drugs. Different from common over-the-counter eye drops, the use of 0.01% atropine sulfate eye drops needs to be under the guidance of an ophthalmologist. The reason is that although its concentration is low, it still belongs to the atropine class of drugs and has certain pharmacological effects and potential side effects. Atropine inhibits the adjustment function of the ciliary muscle of the eyeball and slows down the growth of the axial length of the eye, thereby controlling the progression of myopia. If used improperly, it may cause problems such as dry eyes, mydriasis, and blurred vision at close range.

As a prescription drug, doctors will evaluate whether it is suitable for use based on the child's age, myopia, axial length and eye health.0.01% Atropine Sulfate Eye Drops will be used to determine the appropriate frequency and course of eye drops. In addition, doctors will also instruct parents on how to correctly dispense, store and conduct follow-up examinations to ensure the efficacy and safety of the medicine. Patients or parents should not buy it by themselves or use it casually to avoid abuse or misuse that may lead to adverse reactions or poor efficacy.
In international and domestic regulations, low-concentration atropine eye drops are included in the prescription management system, and its prescription attributes ensure medical supervision and rational use, while reducing the risk of misuse in children. After obtaining the prescription, parents should strictly follow the doctor's instructions and regularly review changes in vision and axial length to ensure that the drug can control the progression of myopia while minimizing side effects.
To sum up,0.01% Atropine Sulfate Eye Drops are prescription drugs and must be evaluated and prescribed by a professional ophthalmologist before use. Parents should strictly abide by the instructions for use and follow-up requirements to achieve safe and effective myopia control goals.
Reference materials:https://www.eikance.com.au/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)